{
    "Trade/Device Name(s)": [
        "Roche Digital Pathology Dx (VENTANA DP 200)",
        "VENTANA DP 200"
    ],
    "Submitter Information": "Ventana Medical Systems, Inc.",
    "510(k) Number": "K232879",
    "Predicate Device Reference 510(k) Number(s)": [
        "K190332"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PSY"
    ],
    "Summary Letter Date": "September 15, 2023",
    "Summary Letter Received Date": "September 18, 2023",
    "Submission Date": "June 14, 2024",
    "Regulation Number(s)": [
        "21 CFR 864.3700"
    ],
    "Regulation Name(s)": [
        "Whole slide imaging system"
    ],
    "Analyte Class(es)": [
        "anatomic pathology"
    ],
    "Analyte(s)": [],
    "Specimen Type(s)": [
        "Formalin-fixed paraffin-embedded (FFPE) tissue"
    ],
    "Specimen Container(s)": [
        "Glass slide"
    ],
    "Instrument(s)/Platform(s)": [
        "VENTANA DP 200 slide scanner",
        "Roche uPath enterprise software",
        "ASUS PA248QV display"
    ],
    "Method(s)/Technology(ies)": [
        "Whole slide imaging",
        "Bright-field digital scanning"
    ],
    "Methodologies": [
        "Digital image acquisition",
        "Image management software"
    ],
    "Submission Type(s)": [
        "System",
        "Scanner",
        "Software",
        "Display"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Digital Pathology Dx (VENTANA DP 200), an automated whole slide imaging and digital pathology system for FFPE tissue slides.",
    "Indications for Use Summary": "For in vitro diagnostic use as an aid to the pathologist to review and interpret digital images of scanned pathology slides prepared from formalin-fixed paraffin-embedded (FFPE) tissue; not for use with frozen section, cytology, or non-FFPE hematopathology specimens.",
    "fda_folder": "Pathology"
}